Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting

Bausch Health Companies Inc. has reported the election of ten directors at its 2025 annual shareholder meeting. Among those elected are Thomas J. Appio and Sarah B. Kavanagh. The voting revealed significant shareholder support, though some votes were withheld for several nominees.

In addition to electing directors, shareholders approved a non-binding advisory vote on executive compensation and the 2025 Employee Stock Purchase Plan. PricewaterhouseCoopers LLP was appointed as the independent public accounting firm.

The company utilized the Toronto Stock Exchange exemption for the Employee Stock Purchase Plan approval, avoiding certain TSX standards. Detailed voting results will be submitted to the SEC on Form 8-K and made publicly accessible.